We are proud that our proprietary patent valuation data is used in the newly launched Nasdaq Innovative Pharmaceuticals and Biotechnology Index (NPI).
The index is designed to track the performance of the 50 companies in the Nasdaq Biotechnology Index (NBI) with the most valuable patent portfolios.
By incorporating our patent valuation data, Nasdaq provides investors with an innovation-focused benchmark for the pharmaceutical and biotechnology sectors.
Further information:
Nasdaq Innovative Pharmaceuticals and Biotechnology Index (NPI)
Let's get into a conversation. Are patent data of interest for you as well? We would be happy to discuss together which solution and application possibilities would be a benefit for you.
